{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:57:07Z","timestamp":1774969027450,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T00:00:00Z","timestamp":1662854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T00:00:00Z","timestamp":1662854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008867","name":"Department of Education of Zhejiang Province","doi-asserted-by":"publisher","award":["Y201941329"],"award-info":[{"award-number":["Y201941329"]}],"id":[{"id":"10.13039\/501100008867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>ABO blood group incompatibility, neonatal sepsis, G-6-PD deficiency, thyroid dysfunction, and hereditary spherocytosis are all probable causes of neonatal hyperbilirubinemia. However, the etiology of some hyperbilirubinemia is extremely complicated, which may be caused by multiple factors, resulting in severe jaundice. We report a case of severe jaundice due to three causes, showing the significance for the investigation of the etiology of neonatal hyperbilirubinemia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>At 96\u00a0h of life, a full-term and vaginal delivery male infant with yellowish discoloration of body was transferred to our hospital. When he entered neonatal intensive care unit on the fourth day after birth, he developed jaundice and the transcutaneous bilirubin was 28\u00a0mg\/dl. Total bilirubin was 540.2\u00a0\u03bcmol\/L, while the indirect bilirubin was 516.7\u00a0\u03bcmol\/L. Both parents and the baby\u2019s blood types were O Rh(D\u2009+), and direct coomb\u2019s test was negative. But mother\u2019s indirect coomb\u2019s test was positive. Investigating for minor blood group revealed that the father\u2019s blood type of Rh was CCDee, the mather\u2019s was ccDEE, and CcDEe for the baby. After intensive phototherapy and double volume exchange transfusion, the total bilirubin remained at 303\u00a0\u03bcmol\/L. At day 10, the bilirubin level was 303.5\u00a0\u03bcmol\/L, intensive phototherapy was continued, and intravenous immunoglobulin was used again. The test for thyroid hormones at day 10, the TSH was 13.334mIU\/L. And the screening for congenital hypothyroidism showed the TSH was 33mIU\/L. Because of the palpable abdominal mass, ultrasound and MRI was done, showed a huge mass in the right adrenal gland. Brainstem auditory evoked potential was performed at day 7, which indicated hearing impairment (65db for left ear and 70db for the right). Euthyrox and intermittent phototherapy were given as following treatment. The jaundice did not subside until the 12th day.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Even if their parents' ABO blood group and Rh (d) are consistent, a Coomb test is required for newborns with hyperbilirubinemia since they may have minor blood group incompatibilities. When bilirubin rises rapidly or the clinical treatment effect is inadequate, additional causes should be aggressively screened. Adrenal ultrasound should be performed on newborns with palpable abdominal mass, anemia and jaundice to determine whether there is adrenal hemorrhage.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-022-03594-7","type":"journal-article","created":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T21:02:27Z","timestamp":1662930147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Severe neonatal hyperbilirubinemia secondary to combined RhC hemolytic disease, congenital hypothyroidism and large adrenal hematoma: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Chengiun","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4273-1341","authenticated-orcid":false,"given":"Chunlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,11]]},"reference":[{"issue":"3","key":"3594_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s12519-021-00422-3","volume":"17","author":"XY Dong","year":"2021","unstructured":"Dong XY, et al. Causes of severe neonatal hyperbilirubinemia: a multicenter study of three regions in China. World J Pediatr. 2021;17(3):290\u20137.","journal-title":"World J Pediatr"},{"issue":"1","key":"3594_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5582\/irdr.2019.01094","volume":"9","author":"A Agrawal","year":"2020","unstructured":"Agrawal A, Hussain KS, Kumar A. Minor blood group incompatibility due to blood groups other than Rh(D) leading to hemolytic disease of fetus and newborn: a need for routine antibody screening during pregnancy. Intractable Rare Dis Res. 2020;9(1):43\u20137.","journal-title":"Intractable Rare Dis Res"},{"issue":"6","key":"3594_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1503\/cmaj.060328","volume":"175","author":"M Sgro","year":"2006","unstructured":"Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175(6):587\u201390.","journal-title":"CMAJ"},{"issue":"12","key":"3594_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.jp.7211394","volume":"25","author":"A Gunlemez","year":"2005","unstructured":"Gunlemez A, et al. Management of severe hyperbilirubinemia in the newborn: adrenal hematoma revisited. J Perinatol. 2005;25(12):803\u20134.","journal-title":"J Perinatol"},{"issue":"12","key":"3594_CR5","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1080\/14767058.2017.1423051","volume":"32","author":"D Sharma","year":"2019","unstructured":"Sharma D, Farahbakhsh N. Neonatal hyperbilirubinemia secondary to combined anti e and anti C isoimmunisation: a literature review. J Matern Fetal Neonatal Med. 2019;32(12):2009\u201311.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"3594_CR6","doi-asserted-by":"publisher","first-page":"102602","DOI":"10.1016\/j.transci.2019.06.027","volume":"59","author":"J Chen","year":"2020","unstructured":"Chen J, Liu F. A case of mild HDFN caused by anti-C, anti-D, and anti-G: Diagnostic strategy and clinical significance of distinguishing anti-G from anti-D and anti-C. Transfus Apher Sci. 2020;59(1):102602.","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"3594_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s12519-020-00339-3","volume":"16","author":"Y Zahed Pasha","year":"2020","unstructured":"Zahed Pasha Y, et al. Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis. World J Pediatr. 2020;16(5):480\u201393.","journal-title":"World J Pediatr"},{"issue":"24","key":"3594_CR8","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.21037\/atm-20-7165","volume":"8","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, et al. Genotype and phenotype correlation in a cohort of Chinese congenital hypothyroidism patients with DUOX2 mutations. Ann Transl Med. 2020;8(24):1649.","journal-title":"Ann Transl Med"},{"issue":"4","key":"3594_CR9","first-page":"e414","volume":"118","author":"C Arriba S\u00e1nchez","year":"2020","unstructured":"Arriba S\u00e1nchez C, et al. Neonatal adrenal hemorrhage in the context of isoimmune neonatal jaundice. Case report Arch Argent Pediatr. 2020;118(4):e414\u20137.","journal-title":"Case report. Arch Argent Pediatr"},{"issue":"02","key":"3594_CR10","first-page":"S57","volume":"37","author":"E Tognato","year":"2020","unstructured":"Tognato E, et al. Neonatal Adrenal Hemorrhage: A Case Series. Am J Perinatol. 2020;37(02):S57-s60.","journal-title":"Am J Perinatol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03594-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03594-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03594-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T21:03:04Z","timestamp":1662930184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03594-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,11]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3594"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03594-7","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,11]]},"assertion":[{"value":"17 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent to participate in this study was provided by the participant\u2019s parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient\u2019s parent provides his consent to submission, and we obtained written consent from the patient's parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"539"}}